Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania
Abstract Background The elimination of Plasmodium vivax malaria requires 8-aminoquinolines, which are contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency due to the risk of acute haemolytic anaemia. Several point-of-care devices have been developed to detect G6PD def...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2021-08-01
|
| Edice: | Infectious Diseases of Poverty |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s40249-021-00889-2 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|